Hence, we may speculate that the elevated levels of GSKIP in SK-N-BE(2) cells treated with BDNF could be due to distinct MYCN-dependent feedback mechanisms for tumor maintenance in a MYCN-amplified context. The gene discussed is GSKIP; the disease is neoplasm.